{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:05:06Z","timestamp":1793639106983,"version":"4.5.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","canadianjournalofophthalmology.ca","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jcjo.2023.10.013","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T19:44:15Z","timestamp":1699040655000},"page":"e431-e434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Risk of ocular adverse events with aromatase inhibitors"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0503-4528","authenticated-orcid":false,"given":"Zhao Xun","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswen","family":"Sriranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9635-3665","authenticated-orcid":false,"given":"Cody","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7071-0863","authenticated-orcid":false,"given":"Victoria","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6237-1964","authenticated-orcid":false,"given":"David","family":"Maberley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahyar","family":"Etminan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2023.10.013_bib0001","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JOP.18.00617","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO Clinical Practice Guideline focused update","volume":"15","author":"Burstein","year":"2019","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0002","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.eye.6701314","article-title":"Detection of oestrogen receptors (ER) alpha and beta in conjunctiva, lacrimal gland, and tarsal plates","volume":"18","author":"Spelsberg","year":"2004","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0003","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/bjo.85.7.877","article-title":"Presence of oestrogen receptor type beta in human retina","volume":"85","author":"Munaut","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0004","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.3390\/ijms23063269","article-title":"Sex hormones and their effects on ocular disorders and pathophysiology: current aspects and our experience","volume":"23","author":"Nuzzi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0005","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4103\/2230-8210.95762","article-title":"Ocular tissue responses to sex hormones","volume":"16","author":"Bajwa","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0006","first-page":"e17565","article-title":"Review of the literature on ocular complications associated with aromatase inhibitor use","volume":"13","author":"Almafreji","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0007","article-title":"A case report of cystoid macular edema, uveitis and vitreomacular traction in a patient taking Anastrozole","volume":"25","author":"Nguyen","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0008","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40264-020-00911-w","article-title":"Disproportionality analysis for pharmacovigilance signal detection in small databases or subsets: recommendations for limiting false-positive associations","volume":"43","author":"Caster","year":"2020","journal-title":"Drug Saf"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0009","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1056\/NEJM199501193320319","article-title":"More on fluoroquinolone antibiotics and tendon rupture","volume":"332","author":"Szarfman","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcjo.2023.10.013_bib0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10549-008-0156-5","article-title":"Vitreo-retinal traction and anastrozole use","volume":"117","author":"Eisner","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0011","first-page":"256","volume":"12","author":"Evans","year":"1998","journal-title":"Systemic risk factors for idiopathic macular holes: a case-control study. Eye (Lond)"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0012","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ajo.2006.08.002","article-title":"Risk factors for posterior vitreous detachment: a case-control study","volume":"142","author":"Chuo","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0013","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0306-4522(98)00340-6","article-title":"Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair","volume":"89","author":"Garcia-Segura","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0014","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ophtha.2019.10.038","article-title":"Prevalence and risk factors of tamoxifen retinopathy","volume":"127","author":"Kim","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jamaophthalmol.2019.0064","article-title":"Association of crystalline retinopathy with anastrozole","volume":"137","author":"Wieder","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0016","article-title":"Imaging tamoxifen retinopathy using spectral-domain optical coherence tomography","volume":"1","author":"Caramoy","year":"2011","journal-title":"GMS Ophthalmol Cases"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0017","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0018","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/01.HYP.0000142893.08655.96","article-title":"Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats","volume":"44","author":"Hinojosa-Laborde","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0019","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/tbj.12633","article-title":"Ocular surface disease in breast cancer patients using aromatase inhibitors","volume":"22","author":"Chatziralli","year":"2016","journal-title":"Breast J"},{"key":"10.1016\/j.jcjo.2023.10.013_bib0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0161-6420(90)32588-5","article-title":"Cyclic changes in conjunctival smears from menstruating females","volume":"97","author":"Kramer","year":"1990","journal-title":"Ophthalmology"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418223003174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418223003174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T17:50:55Z","timestamp":1726595455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418223003174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0008418223003174"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2023.10.013","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of ocular adverse events with aromatase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2023.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of Canadian Ophthalmological Society.","name":"copyright","label":"Copyright"}]}}